CELTAXSYS, INC.

Profile

Company Names

CELTAXSYS, INC.

Addresses

201 17TH STREET, SUITE 530, ATLANTA, GA 30363

ATDC BIOSCIENCES CENTER, 0390, 311 FERST DRIVE, ATLANTA, GA 30332

Phone Numbers

470-206-0153
404-920-0700

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2007

State Incorporated:

DE

Total Amount Raised:

$27,900,371.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2015-06-03 
$21,628,985.00 
$40,003,981.00 
$18,374,996.00 
Equity 
2
2010-10-25 
$4,231,386.00 
$10,653,500.00 
$6,422,114.00 
Equity 
1
2009-05-07 
$2,040,000.00 
$5,000,000.00 
$2,960,000.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
SANJEEV 
 
AHUJA, M.D. 
EXECUTIVE OFFICER
CELTAXSYS, INC.
GERRY 
 
BRUNK 
DIRECTOR
CARDIAC DIMENSIONS INC   |  DC DEVICES, INC.   |  CELTAXSYS, INC.   |  CORVIA MEDICAL, INC.   |  ENDOTRONIX INC   |  ENGAGE THERAPEUTICS, INC.   |  HISTOSONICS, INC.   |  CYRANO THERAPEUTICS, INC.   |  PIC THERAPEUTICS, INC.   |  CADENCE NEUROSCIENCE, INC.   |  GENEP, INC.   |  SPECTRAWAVE, INC.
MATTHEW 
S. 
DONTZIN 
DIRECTOR
CELTAXSYS, INC.
GREG 
 
DUNCAN 
EXECUTIVE OFFICER, DIRECTOR
CELTAXSYS, INC.   |  INNOVATIVE MED CONCEPTS, LLC
MAXIM 
 
GORBACHEV 
DIRECTOR
MIRAMAR LABS INC   |  CELTAXSYS, INC.   |  MIRAMAR LABS, INC.   |  MIRAMAR LABS, INC.
RALPH 
A. 
GROSSWALD 
EXECUTIVE OFFICER
CELTAXSYS, INC.
MICHAEL 
 
HANLEY 
DIRECTOR, EXECUTIVE OFFICER
CELTAXSYS, INC.   |  PSYLIN NEUROSCIENCES INC   |  ORBITE ALUMINAE INC.   |  NUVEI CORP   |  ALTO NEUROSCIENCE, INC.
JAN 
M. 
LODAL 
DIRECTOR
CELTAXSYS, INC.
MICHAEL 
W. 
MASTERS 
DIRECTOR
MARLIN FUND OFFSHORE LTD /NY   |  MARLIN FUND II LP   |  MARLIN FUND L P   |  CELTAXSYS, INC.   |  MARLIN FUND II, LIMITED PARTNERSHIP   |  MARLIN FUND, LIMITED PARTNERSHIP   |  MARLIN FUND OFFSHORE II LTD.   |  MARLIN FUND III, LIMITED PARTNERSHIP   |  MSS GB SPV LP   |  MSS VC SPV LP
H. 
DANIEL 
PEREZ, M.D. 
DIRECTOR
CELTAXSYS, INC.
WILLIAM 
P. 
REDDICK 
EXECUTIVE OFFICER, DIRECTOR
CELTAXSYS, INC.
ERIC 
 
SPRINGMAN 
EXECUTIVE OFFICER
CELTAXSYS, INC.
NICOLE 
 
VITULLO 
DIRECTOR
MARINUS PHARMACEUTICALS INC   |  DP VIII ASSOCIATES, L.P.   |  DOMAIN PARTNERS VIII, L.P.   |  VENTIRX PHARMACEUTICALS INC   |  ESPERION THERAPEUTICS, INC.   |  CELATOR PHARMACEUTICALS INC   |  ABREXA PHARMACEUTICALS, INC.   |  VENTIRX PHARMACEUTICALS INC.   |  DOMAIN PARTNERS IX, L.P.   |  CELTAXSYS, INC.   |  COTERA, INC.   |  EXALYS THERAPEUTICS, INC.   |  ANTIOS THERAPEUTICS INC.   |  MARINUS PHARMACEUTICALS, INC.   |  ALLAY THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2015-06-17
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-06-03 
2010-10-29
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-10-25 
2009-05-07
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2009-05-07 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
LIVINGSTON SECURITIES, LLC
147364
LIVINGSTON SECURITIES, LLC
147364